|
Volumn 36, Issue 1, 1986, Pages 42-47
|
National institutes of health consensus development conference statement: Adjuvant chemotherapy for breast cancer. september 9‐11, 1985
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BREAST;
BREAST CANCER;
CANCER CHEMOTHERAPY;
EDITORIAL;
ENDOCRINE SYSTEM;
HORMONAL THERAPY;
HUMAN;
LYMPH NODE METASTASIS;
LYMPHATIC SYSTEM;
PRIORITY JOURNAL;
THERAPY;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AXILLA;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
DRUG EVALUATION;
FEMALE;
HUMAN;
LIFE EXPECTANCY;
LYMPH NODES;
MENOPAUSE;
MIDDLE AGE;
NATIONAL INSTITUTES OF HEALTH (U.S.);
PROGNOSIS;
QUALITY OF LIFE;
RECEPTORS, ESTROGEN;
TAMOXIFEN;
UNITED STATES;
|
EID: 0022466504
PISSN: 00079235
EISSN: 15424863
Source Type: Journal
DOI: 10.3322/canjclin.36.1.42 Document Type: Article |
Times cited : (21)
|
References (0)
|